Clove used as a kitchen spice in typical culinary amounts poses no well-documented threat to people with kidney disease, but concentrated forms like clove oil or high-dose eugenol supplements are a different story. Eugenol, the compound responsible for clove’s sharp, warm flavor, has a narrow window between “potentially helpful” and “potentially harmful” for renal tissue, and that window shrinks further when kidneys are already compromised. The research so far is almost entirely from animal models, which means firm clinical guidelines for kidney patients do not yet exist.
How Eugenol Affects Kidneys Depends Heavily on Dose
The most direct evidence on clove’s renal effects comes from a 2025 study that gave eugenol to healthy rats at three dose levels and tracked what happened to their kidneys. At the lowest dose tested, the kidneys showed changes in antioxidant capacity and blood vessel density but no damage to function or structure. A moderate dose left kidney tissue looking normal under a microscope but disrupted a key ion-transport enzyme. At the highest dose, things got noticeably worse: serum sodium, potassium, and chloride levels all rose, that same ion-transport enzyme was inhibited more strongly, and the protective brush border lining the kidney’s filtering tubes started to thin out.
1PubMed Central. Dose-related effects of eugenol: Exploring renal functionality and morphology in healthy Wistar ratsThat pattern matters for kidney patients because it tells you two things at once. First, eugenol is not inherently toxic to the kidney at low exposures. Second, the margin of safety narrows quickly as the dose climbs. In a person whose kidneys already struggle to regulate electrolytes or clear waste products, the disruptions seen at higher doses in animals could translate into real clinical problems much sooner than they would in someone with fully functioning kidneys.
Animal Studies That Show Kidney Protection
Somewhat paradoxically, several animal studies have found that eugenol and clove extracts can actually shield kidneys from damage caused by toxins and drugs. In one experiment, a water-based clove extract given to rats with folic-acid-induced kidney injury restored creatinine, urea, uric acid, and electrolyte levels close to normal. The extract also tamped down markers of oxidative stress and boosted the activity of protective antioxidant enzymes. Kidney tissue examined under a microscope showed clear improvement compared to untreated injured kidneys.2Current Chemical Biology. Clove Aqueous Extract Alleviates Acute Kidney Injury Induced by Folic Acid in Rats
A separate study tested eugenol against cisplatin, a chemotherapy drug notorious for damaging kidneys. Mice that received eugenol before cisplatin injection had significantly improved serum urea and creatinine levels compared to those that got cisplatin alone. The protective effect scaled with the eugenol dose, and tissue damage scores improved progressively as the dose increased.3Pakistan Journal of Pharmaceutical Sciences. Nephroprotective role of eugenol against cisplatin-induced acute kidney injury in mice
In a chronic kidney injury model, rats exposed to a chemical toxin and then treated with eugenol showed restored kidney function and improved tissue architecture. Serum creatinine and urea, both of which had spiked after the toxic exposure, came back down with eugenol treatment.4Elsevier / Life Sciences. Nephroprotective potential of eugenol in a rat experimental model of chronic kidney injury; targeting NOX, TGF-β, and Akt signaling A related compound, methyl eugenol, has been shown to protect mouse kidneys from oxidative damage by boosting the activity of an internal defense system that activates antioxidant genes.5PubMed Central. Methyl eugenol protects the kidney from oxidative damage in mice by blocking the Nrf2 nuclear export signal through activation of the AMPK/GSK3β axis
These findings paint a genuinely interesting picture, but they need a large asterisk next to them. Every one of these studies was performed in rodents. The doses were controlled precisely, the animals were healthy at baseline (except for the intentionally induced injury), and the exposures were standardized in ways that do not reflect how a person with chronic kidney disease would actually use clove. No human clinical trial has tested clove or eugenol as a kidney-protective agent. Until that research exists, these results are best understood as early signals, not clinical recommendations.
When Clove Oil Becomes Acutely Dangerous
Clove oil is roughly 80 to 90 percent eugenol by weight, making it one of the most concentrated natural sources of the compound. That concentration creates a real poisoning risk, especially when the oil is ingested rather than applied topically. A published case report describes a 15-month-old child who swallowed about 10 milliliters of clove oil and developed fulminant liver failure within 24 hours. The child’s blood urea and creatinine also spiked sharply, indicating acute kidney stress on top of the liver damage.6PubMed Central. Essential oil poisoning: N-acetylcysteine for eugenol-induced hepatic failure and analysis of a national database
This is an extreme case involving a toddler and a large volume of undiluted oil, so it does not tell you much about what happens when an adult sprinkles ground cloves on a pie. But it does illustrate how rapidly concentrated eugenol overwhelms the body’s detox machinery. For kidney patients whose organs are already working at reduced capacity, the threshold for trouble is presumably lower than it would be for a healthy adult. Even a few drops of undiluted clove oil swallowed by mistake could present a disproportionate challenge to kidneys that are struggling to keep up.
Blood Pressure Effects That Kidney Patients Should Know About
High blood pressure is both a cause and a consequence of chronic kidney disease, so anything that meaningfully lowers blood pressure is relevant to this population. Eugenol does exactly that, at least in animal models, through multiple mechanisms. It relaxes blood vessel walls by blocking calcium channels in smooth muscle cells, the same basic approach used by prescription calcium-channel blockers like amlodipine.7PubMed Central. Eugenol dilates rat cerebral arteries by inhibiting smooth muscle cell voltage-dependent calcium channels In rats with experimentally induced hypertension, eugenol showed dose-dependent blood-pressure-lowering effects.8European Journal of Pharmacology. Cardiovascular protective properties of the natural product eugenol
Another study found that injecting eugenol into anesthetized rats caused an immediate drop in blood pressure followed by a sustained period of lower-than-baseline pressure. The effect depended on a specific receptor in the lining of blood vessels, meaning the compound was acting directly on the vascular system rather than just sedating the animal.9PubMed Central. Eugenol dilates mesenteric arteries and reduces systemic BP by activating endothelial cell TRPV4 channels
For a kidney patient already taking blood-pressure medication, this raises an obvious concern about additive effects. If you are on an antihypertensive drug and then consume a concentrated eugenol supplement, the combined blood-pressure drop could potentially lead to dizziness, fainting, or reduced blood flow to the kidneys themselves. A pinch of ground cloves in a recipe is unlikely to produce enough circulating eugenol to matter, but a high-dose supplement or a few milliliters of clove oil taken orally could be a different situation entirely. This is the kind of interaction that rarely shows up on drug-interaction databases because clove is classified as a food, not a medication.
The Blood-Thinning Problem
Many people with advanced kidney disease take anticoagulants or antiplatelet drugs, either because of dialysis access maintenance, cardiovascular risk, or both. Eugenol has been shown to suppress platelet activation even at very low concentrations. In one study, a concentration as small as 2 micromoles was enough to inhibit platelet clumping triggered by collagen and arachidonic acid. In mice treated with a clot-promoting agent, eugenol reduced the number of blocked lung vessels without extending bleeding time.10PubMed Central. Eugenol Suppresses Platelet Activation and Mitigates Pulmonary Thromboembolism in Humans and Murine Models
On the surface, that last detail sounds reassuring: less clotting without more bleeding. But in a patient already taking warfarin, heparin, or a direct oral anticoagulant, any additional antiplatelet activity could shift the balance. Kidney disease itself can alter drug metabolism and prolong the effects of blood thinners, so stacking eugenol on top creates an unpredictable combination. If you are on anticoagulant therapy and considering clove supplements, this is worth raising with your nephrologist, not because culinary clove is likely to cause trouble, but because concentrated eugenol products might.
Electrolyte Concerns for People on Restricted Diets
Potassium management is a daily reality for many kidney patients, particularly those on dialysis or with advanced chronic kidney disease. Clove buds do contain potassium, as most plant-based foods do, but the amounts consumed through normal seasoning are tiny. A quarter teaspoon of ground cloves contains roughly 8 to 10 milligrams of potassium, which is nutritionally insignificant next to, say, the 400-plus milligrams in a medium banana.
The more relevant potassium concern comes from the high-dose animal data mentioned earlier. When rats were given the highest eugenol dose tested, their serum potassium rose along with sodium and chloride.1PubMed Central. Dose-related effects of eugenol: Exploring renal functionality and morphology in healthy Wistar rats That electrolyte disruption appears to stem from eugenol interfering with the ion-transport enzyme in kidney tubules rather than from the potassium content of the compound itself. For someone whose kidneys already cannot efficiently excrete potassium, even a modest interference with tubular ion transport could theoretically push levels into a dangerous range. Again, this is a concentrated-dose problem, not a cooking-spice problem.
Heavy Metal Contamination in Clove Products
An angle that rarely comes up in conversations about clove safety is the possibility that the spice itself carries contaminants. A study examining clove buds grown in Zanzibar found lead concentrations that fell within accepted international limits but measured cadmium levels well above what most guidelines consider safe, ranging from roughly 2.6 to 8 parts per million across different growing sites.11Open Access Library Journal. Heavy Metals Content in Cloves Spices (Syzygium aromaticum) Cultivated in Zanzibar
Cadmium is particularly bad news for kidneys. It accumulates in the body over years and concentrates in the renal cortex, where it damages the tubular cells responsible for reabsorbing nutrients and filtering waste. For someone with healthy kidneys, trace cadmium from spices is generally handled without issue because the exposure is small and intermittent. For someone with chronic kidney disease, clearance of cadmium is already impaired, so any additional load matters more. This does not mean all clove products are contaminated; growing conditions, soil quality, and processing methods vary enormously. But it does mean that kidney patients who use clove frequently or in supplement form might want to look for products that have been independently tested for heavy metals.
Clove Supplements Versus Clove as a Spice
The recurring theme across all of these concerns is the gap between culinary use and concentrated supplementation. Ground cloves sprinkled into food deliver eugenol in very small, dilute amounts that get absorbed slowly alongside other food components. A whole clove steeped in tea contributes even less. These exposures are far below the doses that caused electrolyte disruption or tubular damage in animals, and they have centuries of safe human use behind them, including in populations with varying kidney health.
Clove oil, clove extract capsules, and eugenol isolates are a fundamentally different proposition. A single capsule of a clove supplement might deliver 200 to 500 milligrams of eugenol, and clove essential oil applied to the gums (a common folk remedy for toothache) can be swallowed in small but significant amounts. For someone with reduced kidney function, these concentrated products bypass the natural dilution that occurs when clove is eaten as a seasoning. The kidneys then have to process a bolus of eugenol that they may not handle as efficiently as healthy kidneys would.
No regulatory body currently publishes a specific eugenol limit for kidney patients. The European Food Safety Authority and the U.S. FDA have both evaluated eugenol and consider it generally recognized as safe in food use, but those assessments are based on general population data, not on people with renal impairment. That regulatory gap means kidney patients are largely on their own when deciding whether a clove supplement is appropriate for them.
What to Actually Do With This Information
If you have chronic kidney disease and enjoy clove in your cooking, the available evidence does not suggest you need to stop. Culinary doses are small enough that the concerning effects seen in animal studies at high doses are not realistically in play. The same goes for the occasional clove tea or clove-flavored baked good.
If you are considering clove oil or a concentrated clove supplement for some perceived health benefit, treat it the way you would treat any unregulated bioactive substance: with caution proportional to how compromised your kidneys are. The blood-pressure-lowering and antiplatelet effects are real enough in animal models that interactions with common kidney-disease medications are plausible. The electrolyte disruption observed at higher eugenol doses is exactly the kind of problem that kidney patients are already monitoring. And the lack of any human clinical trial specifically addressing clove use in kidney disease means there is no evidence-based dose range anyone can point to as definitively safe for this population.
Mentioning clove supplements to your nephrologist or renal dietitian may feel like an odd conversation, but it is the right one to have. These professionals can evaluate your current medication list, your latest lab values, and your stage of kidney disease to give you a more personalized answer than any general article can.
Why the Research Stays Stuck in Animal Models
It is worth asking why, given decades of clove use in traditional medicine and the growing interest in plant-based nephroprotective agents, no one has run a proper human trial. Part of the answer is economic. Eugenol is a naturally occurring compound that cannot be patented, which means pharmaceutical companies have little financial incentive to fund the expensive clinical trials needed for regulatory approval. Another part is practical: kidney patients are a medically complex population with widely varying stages of disease, comorbidities, and medication regimens, making trial design difficult and recruitment slow.
There is also the issue of dosing uncertainty. The animal studies that show kidney protection use controlled doses of pure eugenol or standardized extracts, administered at precise intervals. Translating those protocols into a human supplement regimen requires pharmacokinetic data that does not yet exist for kidney-impaired populations. How quickly does a person with a GFR of 30 clear eugenol compared to someone with normal function? Nobody knows. Until someone funds that basic pharmacokinetic work, clinical trials remain impractical, and the guidance for kidney patients remains “probably fine in food amounts, be careful with everything else.”